NCT07288333: Evaluation of NBI-1117570 in Inpatient Adults With Schizophrenia
- State
- Under way
- Phase
- Phase 2
- People
- 120 planned
- Started
- 16 Feb 2026
- Primary completion
- Aug 2027
- Arms
- NBI-1117570: Lower-dose, NBI-1117570: Higher-dose
- Results
- None posted
- 17 Dec 2025: Trial registered
- 16 Feb 2026: Trial started